Nutritional outcomes following small bowel transplantation - The first year post-operative nutritional nadir.

R. Gao,C. Kratzing,C. Pither,L. Sharkey,S. West,A. Butler,J. Woodward,S. Duncan,J. Green,B. Chukualim,S. Gabe,N. Jamieson,S. Middleton

DOI: https://doi.org/10.1016/j.clnesp.2015.03.033

2015-10-01

Clinical Nutrition ESPEN

Abstract:

What problem does this paper attempt to address?

Predictors of Durable Remission After Successful Surgery for Cushing Disease: Results From the Multicenter RAPID Registry

Matthew C Findlay,Sam Tenhoeve,Jeremiah Alt,Robert C Rennert,William T Couldwell,James Evans,Sarah Collopy,Won Kim,William Delery,Donato Pacione,Albert Kim,Julie M Silverstein,Michael R Chicoine,Paul Gardner,Lauren Rotman,Kevin C J Yuen,Garni Barkhoudarian,Juan Fernandez-Miranda,Carolina Benjamin,Varun R Kshettry,Gabriel Zada,Jamie Van Gompel,Michael P Catalino,Andrew S Little,Michael Karsy

DOI: https://doi.org/10.1227/neu.0000000000003042

IF: 5.315

2024-10-01

Neurosurgery

Abstract:Background and objective: Cushing disease (CD) affects mortality and quality of life along with limited long-term remission, underscoring the need to better identify recurrence risk. The identification of surgical or imaging predictors for CD remission after transsphenoidal surgery has yielded some inconsistent results and has been limited by single-center, single-surgeon, or meta-analyses studies. We sought to evaluate the multicenter Registry of Adenomas of the Pituitary and Related Disorders (RAPID) database of academic US pituitary centers to assess whether robust nonhormonal recurrence predictors could be elucidated. Methods: Patients with treated CD from 2011 to 2023 were included. The perioperative and long-term characteristics of CD patients with and without recurrence were assessed using univariable and multivariable analyses. Results: Of 383 patients with CD from 26 surgeons achieving postoperative remission, 288 (75.2%) maintained remission at last follow-up while 95 (24.8%) showed recurrence (median time to recurrence 9.99 ± 1.34 years). Patients with recurrence required longer postoperative hospital stays (5 ± 3 vs 4 ± 2 days, P = .002), had larger average tumor volumes (1.76 ± 2.53 cm 3 vs 0.49 ± 1.17 cm 3 , P = .0001), and more often previously failed prior treatment (31.1% vs 14.9%, P = .001) mostly being prior surgery. Multivariable hazard prediction models for tumor recurrence found younger age (odds ratio [OR] = 0.95, P = .002) and Knosp grade of 0 (OR = 0.09, reference Knosp grade 4, P = .03) to be protective against recurrence. Comparison of Knosp grade 0 to 2 vs 3 to 4 showed that lower grades had reduced risk of recurrence (OR = 0.27, P = .04). Other factors such as length of stay, surgeon experience, prior tumor treatment, and Knosp grades 1, 2, or 3 failed to reach levels of statistical significance in multivariable analysis. Conclusion: This multicenter study centers suggests that the strongest predictors of recurrence include tumor size/invasion and age. This insight can help with patient counseling and prognostication. Long-term follow-up is necessary for patients, and early treatment of small tumors may improve outcomes.
Prospective Evaluation of Transsphenoidal Pituitary Surgery in Patients with Cushing's Disease: Delayed Remission and the Role of Postsurgical Cortisol as a Predictive Factor

Athanasios Saratziotis,Maria Baldovin,Claudia Zanotti,Sara Munari,Diego Cazzador,Enrico Alexandre,Luca Denaro,Jiannis Hajiioannou,Enzo Emanuelli

DOI: https://doi.org/10.3390/healthcare12181900

2024-09-22

Health Care

Abstract:Background. Transsphenoidal surgery is the treatment of choice for Cushing's disease. Successful surgery is associated with subnormal postoperative serum cortisol concentrations and cortisoluria levels, which may guide decisions regarding immediate reoperation. Remission is defined as the biochemical reversal of hypercortisolism with the re-emergence of diurnal circadian rhythm. Methods. A single-center prospective cohort study was conducted among thirty-three patients who underwent transsphenoidal pituitary surgery for Cushing's disease. Postoperative surgical outcomes, daily morning cortisolemia, and 24 h urinary-free cortisol from the first to the fifth morning were evaluated. Results. All patients underwent surgery, with a remission rate of 81.2%. Of the 26 patients who achieved early remission, 92% remained in remission. Two patients (7.7%) showed recurrence of Cushing's disease during a mean follow-up of 81.7 months. Early postoperative hypocortisolism suggests complete removal of the tumor, correlating with high rates of remission (p 138 nmol/L, there was a gradual late remission. Conclusions. In our cohort of patients, the endoscopic transsphenoidal approach was safe and effective in the treatment of Cushing's disease. We demonstrated that serum and urinary cortisol concentrations did not experience significant fluctuations from the first to the fifth day. This constitutes an accurate predictor of durable remission, comprising a distinctive finding in the intermediate term by our team.

health care sciences & services,health policy & services
Bilateral inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome with unknown origin

Lin LU,Feng GU,Xiao-bo ZHANG,Zhao-lin LU,Zheng-pei ZENG,Huai-cheng LIU,An-li TONG,Xin YUE,Yong FU,Zheng-yu JIN,Zu-yuan REN,Ren-zhi WANG,Bing XING

DOI: https://doi.org/10.3760/cma.j.issn.1001-2346.2009.012.022

2009-01-01

Abstract:Objective To evaluate the value of inferior petrosal sinus sampling in ACTH-dependent Cushing's syndrome with unknown origin.Method IPSS was carried out for the diagnosis of 20 cases of ACTH dependent Cushing's syndrome who had not been identified of diagnosis after a series of dexamethasone suppression tests and radiological examinations from Jan,2008 to Jan 2009.The ratio of plasma ACTH concentration between inferior petrosal sinus and peripheral veins was assayed.The sensitivity and specificity of diagnosis of the Cushing's disease were estimated.Results The basal ratio of ACTH concentration between inferior petrosal sinus and peripheral veins was ＞2 in 18 cases.13 cases underwent transphenoidal surgery with pathological diagnosis of pituitary ACTH adenoma;1 patient chose γ knife treatment and 4 patients chose somatostatin therapy with relieve of the disease.The basal ratio of ACTH concentration between inferior petrosal sinus and peripheral veins was ＜2 in 2 cases. One pulmonary node was removed by surgery with pathological diagnosis of carcinoid in 1 patient.One transphenoidal surgery was still undergone according to the clinical features in the other patient with pathological diagnosis of pituitary ACTH adenoma. The sensitivity and specify of inferior petrosal sinus sampling for the diagnosis of Cushing's disease in this study were 93% and 100% respectively.Conclusion Inferior petrosal sinus sampling is a safe technique with infrequent complications. It has great value in the differential diagnosis of ACTH-dependent Cushing's disease with unknown origin.
Clinico-radiological parameters, biochemical and molecular alterations predicting remission and recurrence after surgical treatment of corticotroph adenomas – Cushing's disease

Nidhisha Sadhwani,Santanu Kumar Bora,S. Deepa,Varidh Katiyar,Amol Raheja,Ajay Garg,Vaishali Suri,Nikhil Tandon,Mehar Chand Sharma,Rajesh Khadgawat,Ashish Suri

DOI: https://doi.org/10.1016/j.wneu.2024.05.014

IF: 2.21

2024-05-11

World Neurosurgery

Abstract:Objectives Endonasal endoscopic transsphenoidal surgery (TSS) and resection of pituitary adenomas is considered to be the gold standard treatment for Cushing's Disease (CD). Even with various recent advances in management, disease persistence and recurrences are common in these patients. The remission rate in the global population after surgery has been reported to vary widely from 64 to 93%. This study aims to determine various clinical, biochemical, radiological and histological factors that correlate with persistence and recurrence in patients with CD. This study also aims to understand the clinicopathological significance of EGFR-MAPK, NF-kB and SHH pathway activation and to study the protein expression levels of activation markers of these pathways viz. c-Fos , c-Jun, GLI-1 , pMEK, NR4A1 and p44 in functioning corticotroph pituitary adenomas. Methods From January 2009 to September 2022, the clinical data of 167 patients who underwent surgical treatment (n=174 surgeries) for Cushing's disease was ambispectively analysed with a median follow up of 8.1 years (1-13.29 years). The preoperative clinical, biochemical, radiological features, operative findings, postoperative clinical and biochemical data, histopathological and molecular profile, were retrieved from electronic records. The patients were followed up to assess the remission status. Results Among the 174 surgeries performed, 140 were primary surgeries, 22 were revision surgeries, 24 surgeries were for paediatric patients and 12 surgeries were performed in patients with Nelson syndrome. In the primary surgery cohort, 74.3% were females and the average age was 28.73 years (SD 10.15). 75% of the patients experienced remission after primary surgery compared to 47.4% in revision surgery. The remission rate in paediatric patients was 55.5%. Post-operative day 1 plasma cortisol (p<0.001; AUC 0.8894 [0.8087-0.9701]) and ACTH (p<0.001; AUC 0.9 [0.7386-1]) levels were seen to be strong independent predictors of remission in the primary surgery cohort. Remission rates after Endoscopic TSS were more than that after microscopic TSS, in patients undergoing primary surgery (81.08% vs 57.14%; p=0.008). Presence of adenoma on histopathological examination (HPE) was also a strong predictor of disease remission (p=0.020). On categorising based on surgical approach and HPE, microscopically operated patients without histopathological evidence of adenoma had significantly higher odds of non-remission (OR 38.1 95% CI 4.2-348.3) compared to endoscopically operated patients with adenoma on HPE. Lower immune reactivity score (IRS) of NR4A1 was found to correlate with higher remission rates (p=0.074). However, none of the molecular markers studied viz. c-Fos , c-Jun, GLI-1, pMEK and p44 showed a significant correlation with the preoperative cortisol values. Conclusion Remission rate after primary surgery is higher as compared to that after revision surgery, and that in paediatric patients is lower as compared to adults. Post-operative day 1 plasma cortisol and ACTH levels are strong independent predictors of remission in the primary surgery cohort. Endoscopic approach with histopathological evidence of adenoma is associated with a higher remission rate and thus endoscopy should be the approach of choice in these patients with the goal of identification of an adenoma on histopathological analysis.

surgery,clinical neurology
Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study

I. Bonaventura,A. Tomaselli,F. Angelini,D. Ferrari,D. De Alcubierre,V. Hasenmajer,E. Sbardella,A. Cozzolino,A. M. Paganini,A. M. Isidori,M. Minnetti,R. Pofi

DOI: https://doi.org/10.1007/s40618-023-02283-1

2024-02-22

Journal of Endocrinological Investigation

Abstract:Abstract Background Limited information exists on postoperative hypocortisolism and hypothalamus–pituitary–adrenal axis recovery in patients with adrenal incidentaloma following unilateral adrenalectomy. We evaluated frequency of postoperative hypocortisolism and predictors for recovery in non-aldosterone-producing adrenocortical adenoma patients after unilateral adrenalectomy. Methods A retrospective analysis of 32 adrenal incidentaloma patients originally included in the ITACA trial (NCT04127552) with confirmed non-aldosterone-producing adrenocortical adenoma undergoing unilateral adrenalectomy from September 2019 to April 2023 was conducted. Preoperative assessments included adrenal MRI, anthropometrics, evaluation of comorbidities, adrenal function assessed via ACTH, urinary free cortisol, and 1 mg dexamethasone suppression test. ACTH and serum cortisol or Short Synacthen test were performed within 6 days, 6 weeks, 6 months, and a year after surgery. Results Six days postoperative, 18.8% of patients had normal adrenal function. Among those with postoperative hypocortisolism, 53.8% recovered by 6 weeks. Patients with earlier adrenal recovery (6 weeks) had lower preoperative 1 mg dexamethasone suppression test (median 1 mg dexamethasone suppression test 76.2 [61.8–111.0] nmol/L vs 260.0 [113.0–288.5] nmol/L, p < 0.001). Univariate analysis showed preoperative 1 mg dexamethasone suppression test negatively related with baseline ACTH levels ( r = − 0.376; p = 0.041) and negatively associated with the 6-week baseline ( r = − 0.395, p = 0.034) and 30-min cortisol levels during Short Synacthen test ( r = − 0.534, p = 0.023). Logistic regression analysis demonstrated preoperative 1 mg dexamethasone suppression test as the only biochemical predictor for 6-week adrenal recovery: ROC curve identified a 1 mg dexamethasone suppression test threshold of 131 nmol/L predicting 6-week recovery with 89.5% sensitivity and 72.7% specificity (AUC 0.87; 95% CI 66.9–98.7, p < 0.001). Other preoperative assessments (tumor size, ACTH levels and anthropometrics) were not associated with postoperative hypothalamus–pituitary–adrenal axis function, but the presence of diabetes was associated with a lower probability of recovery (OR = 24.55, p = 0.036). ACTH levels increased postoperatively in all patients but did not predict hypothalamus–pituitary–adrenal axis recovery. Conclusions The preoperative 1 mg dexamethasone suppression test cortisol value and presence of diabetes are the only relevant predictor of hypothalamus–pituitary–adrenal axis recovery in patients with non-aldosterone- producing adrenocortical adenoma undergoing surgery, regardless other clinical and biochemical variables. Notably, pre- and postoperative ACTH levels did not predict hypothalamus–pituitary–adrenal axis recovery. These findings point towards the potential for saving resources by optimizing their allocation during follow-up assessments for patients with non-aldosterone-producing adrenocortical adenoma undergoing unilateral adrenalectomy.

endocrinology & metabolism
ODP639 The Occurrence and Predictors of Postoperative Adrenal Insufficiency for Patients With Subclinical Cushing's Syndrome

Zhu Da-long,Chen Huan,Liu Meng-si,Li Ping,Zeng Yang-jie,Wang Yi-jie,Lou Yuan,Tian Zhao-yang,Lou Yuan

DOI: https://doi.org/10.1210/jendso/bvac150.162

2022-01-01

Journal of the Endocrine Society

Abstract:Abstract Objective To identify the occurrence and predictive factors of postoperative adrenal insufficiency in patients with subclinical Cushing's syndrome (SCS), and try to provide evidence for decision-making in SCS management. Methods The present retrospective analysis included 77 patients who underwent unilateral laparoscopic adrenalectomy for SCS between December 2011 and April 2021. Among them, 59 patients with complete follow-up data were included. We compared clinical characteristics of patients with and without postoperative adrenal insufficiency. The logistic regression model was used to find the potential risk factors in predicting the occurrence of postoperative adrenal insufficiency. The receiver operating characteristic (ROC) curve was used to evaluate the predictive values. Results We included 59 patients, of whom the incidence of postoperative adrenal insufficiency is 42.37%. The circadian rhythms of adrenocorticotropic hormone (ACTH) and cortisol disappeared in both two groups. Compared patients without postoperative adrenal insufficiency, patients with postoperative adrenal insufficiency were characterized by suppressed plasma ACTH level [1.11(1.11, 1.83) pmol/L vs 2.56(1.16, 4.63) pmol/L], elevated midnight cortisol level [268. 00(164. 00, 347.50) nmol/L vs 181.50(156.32, 227. 00) nmol/L] and increased cortisol level after 1 mg overnight dexamethasone suppression test (DST) [281. 00(241. 00, 396.64) nmol/L vs 172.50(144. 05, 215.25) nmol/L] (all P < 0. 05). Multivariate logistic regression analysis showed that the serum cortisol after a 1 mg-DST was the only independent predictive factor for the occurrence of postoperative adrenal insufficiency. The ROC curve showed that the best cut-off value of the serum cortisol after a 1 mg-DST was 233 nmol/L, with a sensitivity of 80. 00% and a specificity of 82.35%. The combination of the serum cortisol after a 1 mg-DST, plasma ACTH and midnight cortisol had the highest predictive accuracy (83. 05%). Conclusion Patients who underwent unilateral laparoscopic adrenalectomy for SCS had a risk of postoperative adrenal insufficiency. The pre-surgical assessment of the serum cortisol after a 1 mg-DST plus elevated midnight cortisol and suppressed plasma ACTH had predictive value for the occurrence of postoperative adrenal insufficiency. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m., Monday, June 13, 2022 1:00 p.m. - 1:05 p.m.
Study of correlative mitigating factors after the surgery for Cushing's disease

Fan Changyan,Shi Xiuhua,Sun Qingfang,Bian Liuguan,Zhao Weiguo,Shen Jiankang,Su Tingwei,Wang Weiqing,Li Xiaoying,Ning Guang

2011-01-01

Abstract:Objective To explore the correlative mitigating factors of Cushing's disease after transsphenoidal surgery.Methods Clinical data of 104 patients with Cushing's disease treated by transsphenoidal surgery were analyzed retrospectively.The patients were divided into remission group and non-remission group according to the early remission postoperatively,and the differences between both groups were analyzed statistically to judge the factors influencing on remission after the surgery for Cushing's disease.Results A significant difference in the plasma cortisol levels at every time point postoperatively was found between remission group and non-remission group(P<0.05),however,the 24 h urinary free cortisol just at the time of 1 to 2 days and 1 month postoperatively showed significant differences(P<0.05).At the third day after 8-mg dexamethasone suppression test,the patients whose plasma cortisol inhibition rate was above 50% accounted for 85.5% in remission group and 62.5% in non-remission group.The remission rate was 86.8% in the patients with positive result for MRI and 61.5% those with negative one.The remission rate was 87.2% in the patients with positive result for pathological examination and 66.7% in those with pathological negative ones.There was statistical significance in the differences above(P<0.05).Conclusions After transsphenoidal surgery of Cushing's disease,the prognosis can be judged by 8-mg dexamethasone suppression test,preoperative MRI,postoperative plasma cortisol level and pathological examination.
1233 A Benchmark for Early Biochemical Success and Long-term Remission After Resection of Corticotroph Adenomas in Cushing Disease

Michael P. Catalino,Dominic Moore,Natasha Ironside,Kathryn Kearns,Le Min,Mary Lee Vance,John Anthony Jane,Edward R. Laws

DOI: https://doi.org/10.1227/neu.0000000000002809_1233

IF: 5.315

2024-04-01

Neurosurgery

Abstract:INTRODUCTION: In Cushing disease, the definition of success after resection of corticotroph adenomas remains unclear given inconsistent pathology and high recurrence rates despite initial biochemical remission. METHODS: We collected 12 years of in-hospital cortisol data after the removal of pathology-confirmed corticotroph adenomas in patients with Cushing disease. A novel cortisol halving time analysis was performed using exponential decay modeling, results were dichotomized a priori, and then applied to an external cohort of patients. Halving time was compared to first post-operative cortisol and nadir cortisol variables by estimating long-term remission and time-to-recurrence using Cox regression modeling and the Kaplan-Meier method. RESULTS: A total of 320 patients met inclusion/exclusion criteria for the final analysis, and 26 of those patients developed recurrent disease. Median follow-up time was 2.1 years, although 62 patients had five years or longer follow-up time. Higher first post-operative cortisol and higher nadir were associated with increased risk of recurrence. Patients who had a first post-operative cortisol = 50 μd/dL were 4.1 times more likely to recur than those with a first post-operative cortisol < 50 μd/dL (HR 4.1, 1.8-9.2; p = 0.0003). Halving time was not associated with recurrence (HR 1.7, 0.8-3.8, p = 0.18). Patients with a nadir cortisol =2 μg/dL were 6.6 times more likely to recur than those with a nadir cortisol of < 2 μg/dL (HR 6.6, 2.6-16.6, p < 0.0001). CONCLUSIONS: Post-operative nadir serum cortisol is the most important cortisol variable associated with recurrence and time-to-recurrence. Compared to first post-operative cortisol and cortisol halving time, a nadir < 2 μg/dL occurring within the first three post-operative days showed the strongest association with long-term remission.

surgery,clinical neurology
The Diagnosis and Surgical Treatment of Pituitary ACTH- secreting Cushing’s Adenoma

ZHANG Nan,LI Shi-Qi,WANG Yong-Fei,WU Jin-Song,ZHAO Yao,SHOU Xue-Fei,ZHANG Xiao-Luo,SHEN Ming,WANG Tao

2012-01-01

Abstract:Aim: To demonstrate the results following surgical treatment of pituitary ACTH-secreting Cushing’s adenoma,analyze the diagnostic modalities of this disease and assess the the factors that influence the outcome.Methods: The clinical data of 29 patients with pituitary ACTH-secreting adenoma were analyzed retrospectively.The preoperative MRI showed that 2 were macroadenoma,14 microadenoma,11 unconfirmed microadenoma and 2 unvisible adenomas.14 patients underwent bilateral inferior petrosal sinus sampling(BIPSS).All the patients were operated via trans-sphenoidal approach.The immediate postoperative biochemical remission(IPBR) was defined as a lower-than 5 μg.dL-1morning serum cortisone level and normal 24 h-urinary free cortisone (24 h-UFC) within 2 days after operation.Results: All the patients were pathologically diagnosed as ACTHsecreting adenomas.The IPBR rate was 79.3%(23/29),the postoperative free cortisone level of the patients ranged between 0.47~4.35 μg.dL-1(mean 2.37 μg.dL-1).The patients with positive MRI results achieved higher IPBR rate than those with negative MRI results(93.75% vs 61.5%).In patients with negative MRI results,the patients underwent(BIPSS) achieved higher IPBR rate than those did not undergo BIPSS(77.8% vs 25%).9 patients in 14(9/14,64.3%) were correctly localized by BIPSS.Conclusion: BIPSS helps localize the lesion preoperatively and possibly helps improve the treatment effect of pituitaryACTH-secreting adenoma.Trans-sphenoidal operation is a preferred treatment of pituitary ACTH-secreting adenoma.Reoperation can be considered for recurrent or refractory cases.Positive preoperative MRI is a good predictive index of remission.
Clinical significance of immediate urine cytology after transurethral resection of bladder tumor in patients with non‐muscle invasive bladder cancer

Y. Shin,Sang Deuk Kim,Jai Seong Cha,M. Kim,Y. Jeong,Hyung-Jin Kim

DOI: https://doi.org/10.1111/j.1442-2042.2011.02766.x

2011-06-01

International Journal of Urology

Abstract:Objectives: To assess the clinical significance of immediate urine cytology (IUC) after transurethral resection of bladder tumor (TURBT) for non‐muscle invasive bladder cancer (NMIBC).
Surgical Results and Predictors of Initial and Delayed Remission for Growth Hormone-Secreting Pituitary Adenomas Using the 2010 Consensus Criteria in 162 Patients from a Single Center

Ming Shen,Yifan Tang,Xuefei Shou,Meng Wang,Qilin Zhang,Nidan Qiao,Zengyi Ma,Zhao Ye,Wenqiang He,Yichao Zhang,Zhengyuan Chen,Zhaoyun Zhang,Hongying Ye,Yiming Li,Shiqi Li,Yao Zhao,Xiang Zhou,Yongfei Wang

DOI: https://doi.org/10.1016/j.wneu.2018.11.179

IF: 2.21

2018-01-01

World Neurosurgery

Abstract:BACKGROUND: The factors associated with initial and delayed remission after growth hormone (GH)-secreting pituitary adenoma excision have not been completely elucidated. METHODS: We recruited 185 consecutive patients who had undergone resection of GH-secreting pituitary adenomas from January 2013 to December 2014 and assessed their tumor characteristics and surgical outcomes. The criteria for initial or delayed remission (using the 2010 consensus criteria) were normalized insulin-like growth factor 1 (IGF-1) levels, GH levels <0.4 mu g/L with an oral glucose tolerance test, and/or random GH levels <1.0 mu g/L at or after the postoperative 3-month (PO3M) follow-up, without adjuvant therapy. RESULTS: Remission was achieved in 92 of 162 patients (56.8%) after surgery alone and was associated with a lower Knosp grade of 0-2 and lower postoperative day 1 GH level on multivariate regression analysis. A baseline IGF-1 index (IGF-1 level/upper limit of normal) of <2.835 predicted for initial remission at the PO3M follow-up (positive predictive value, 95.3%; negative predictive value, 36.6%; P < 0.001). The PO3M IGF-1 index was significantly lower in the delayed remission group than in the nonremission group. Furthermore, the former had had fewer invasive tumors (1.23 +/- 0.21 vs. 1.77 +/- 0.37 [9.52% vs. 76.47%]; P < 0.001). A PO3M IGF-1 index of <1.485 predicted for delayed remission during subsequent follow-up (positive predictive value, 84.6%; negative predictive value, 92.3%; P < 0.001). CONCLUSIONS: A lower Knosp grade of 0-2 and lower postoperative day 1 GH level were independent predictors of surgical remission. The baseline IGF-1 and PO3M IGF-1 indexes might predict for initial and delayed remission, respectively.
Preoperative Prognostic Nomogram for Prophylactic Steroid Treatment of Patients with Subclinical Cushing’s Syndrome

Dengqiang Lin,Jinglai Lin,Xiaoyi Hu,Yujun Liu,Jianping Zhang,Li Zhang,Jingjing Jiang,Xiaomu Li,Jianming Guo

DOI: https://doi.org/10.21037/tau-20-1108

2021-01-01

Translational Andrology and Urology

Abstract:Background: Subclinical Cushing's syndrome (SCS) is incidentally detected in a growing number of patients by advanced imaging technology. However, there is no consensus on the clinical management of SCS, especially in terms of whether prophylactic steroid treatment is necessary following adrenalectomy. In this study we developed a model based on preoperative indices for predicting postoperative adrenal insufficiency (AI) that can guide therapeutic decision-making. Methods: A total of 27 patients with SCS who underwent adrenalectomy between August 2016 and August 2019 were enrolled and divided into AI and non-AI groups. Cox proportional hazards regression and least absolute shrinkage and selection operator analyses were performed to select relevant clinical parameters. The predictive performance of our model was evaluated by time-dependent receiver operating characteristic (ROC) curve and calibration curve analyses. Results: Five clinical parameters (apolipoprotein Al, neutrophil-lymphocyte ratio, total cholesterol, platelet count, and homocysteine) were identified as the best predictors of replacement therapy (12 . 1). The areas under the ROC curve for our prognostic model were 0.833, 0.945, and 0.967 for 3-, 4-, and 5-day non-(N)RT, respectively. The calibration curve of the 5 independent RT-related markers showed a good fit between nomogram-predicted probability of NRT and actual NRT, suggesting that our model has good predictive value. Conclusions: Our prognostic nomogram can help clinicians identify patients with AI who would benefit from RT so that timely treatment can be initiated.
Machine learning in predicting early remission in patients after surgical treatment of acromegaly: a multicenter study

Nidan Qiao,Ming Shen,Wenqiang He,Min He,Zhaoyun Zhang,Hongying Ye,Yiming Li,Xuefei Shou,Shiqi Li,Changzhen Jiang,Yongfei Wang,Yao Zhao

DOI: https://doi.org/10.1007/s11102-020-01086-4

2020-01-01

Pituitary

Abstract:Purpose Accurate prediction of postoperative remission is beneficial for effective patient-physician communication in acromegalic patients. This study aims to train and validate machine learning prediction models for early endocrine remission of acromegalic patients. Methods The training cohort included 833 patients with growth hormone (GH) secreting pituitary adenoma from 2010 to 2018. We trained a partial model (only using pre-operative variables) and a full model (using all variables) to predict off-medication endocrine remission at six-month follow-up after surgery using multiple algorithms. The models were validated in 99 prospectively collected patients from a second campus and 52 patients from a third institution. Results C-statistic and the accuracy of the best partial model was 0.803 (95% CI 0.757–0.849) and 72.5% (95% CI 67.6–77.5%), respectively. C-statistic and the accuracy of the best full model was 0.888 (95% CI 0.861–0.914) and 80.3% (95% CI 77.5–83.1%), respectively. The c-statistics (and accuracy) of using only Knosp grade, total resection, or postoperative day 1 GH level as the single predictor were lower than our partial model or full model (p < 0.001). C-statistics remained similar in the prospective cohort (partial model 0.798, and full model 0.903) and in the external cohort (partial model 0.771, and full model 0.871). A web-based application integrated with the trained models was published at https://deepvep.shinyapps.io/Acropred/ . Conclusion We developed and validated interpretable and applicable machine learning models to predict early endocrine remission after surgical resection of a GH-secreting pituitary adenoma. Predication accuracy of the trained models were better than those using single variables.
A predicted model for postoperative seizure outcomes after the surgical resection of supratentorial cavernous malformations.

Chun Wang,Xiaobo Yu,Sudeep Shrestha,Cong Qian,Lin Wang,Gao Chen

DOI: https://doi.org/10.1097/MD.0000000000004078

IF: 1.6

2016-01-01

Medicine

Abstract:To explore a predicted model for postoperative seizure outcomes after the surgical resection of supratentorial cavernous malformations.This study was a retrospective review of consecutive patients with cerebral supratentorial cavernous malformations presenting with seizures. All patients underwent surgical resection of CCMs. Univariate and multivariate analyses were performed to determine the predictive value of the preoperative seizure frequency, seizure type, seizure duration, lesion location, lesion size, and the presence of residual hemosiderin.A total of 43 patients met the inclusion criteria. After a mean follow-up period of 40.95 months, 34 patients who were free from postoperative seizures were classified into Engel class I, and the remaining 9 patients were classified into Engel classes II-IV. A univariate analysis showed that the seizure frequency ((2) = 13.440, P = 0.004) and seizure duration ((2) = 5.145, P = 0.023) prior to surgery were associated with a worse postoperative seizure prognosis. Other covariates including age at onset, gender, a history of the medications taken, smoking status, family history, lesion characteristics, and the role of hemosiderin were not related to seizure outcomes. Logistic regression results demonstrated that the preoperative seizure frequency was an effective predictor (P = 0.004). The receiver operating characteristic curve indicated that area under the curve for the preoperative seizure frequency test was 0.833 (95% confidence interval 0.709-0.957, P = 0.002).The preoperative seizure frequency was a prognostic factor for postoperative seizure outcomes after surgical resection of supratentorial cavernous malformations. To obtain a favorable prognosis for CCM patients with preoperative seizures, early intervention might be a better choice.
Retrospective analysis of the outcomes of endoscopic transsphenoidal surgery for Cushing's disease

Anurag Srivastava,Anmol Anant Dobriyal,Anmol Singh Randhawa,Pavan Kumar Jain,Shiteez Agrawal,Jitendra Singh Verma,Pankaj Gupta,Bhawani Shanker Sharma,Yogesh Agrawal,Medha Bhardwaj

DOI: https://doi.org/10.25259/SNI_278_2024

2024-07-12

Abstract:Background: The first-line surgical management of an adrenocorticotropic hormone (ACTH)--secreting pituitary adenoma causing Cushing's disease (CD) is endoscopic transsphenoidal resection of the tumor. This study was performed to assess postoperative (postop) complications and remission in endoscopic surgically resected cases of CD. Methods: Data of patients who underwent endoscopic transsphenoidal surgery (ETSS) for CD were collected from the neurosurgery department at a tertiary care center in a retrospective manner from January 2015 to February 2022 and analyzed. Postoperative remission was categorized as - early morning serum cortisol <138 nmol/L within 7 days of the surgery, as per the Endocrine Society Guidelines, with significant clinical improvement in features of hypercortisolism in the operated patient and strict cutoff rate of <50 nmol/L at postop day 3 was also utilized, to look for the early identification of remission. Results: A total of 41 patients were identified who underwent 44 ETSS during the same timeframe. Preoperative magnetic resonance imaging localized an adenoma in all 41 patients, out of which 32 were microadenoma, and nine were macroadenoma (2 with cavernous sinus invasion). Intrapetrosal sinus sampling was performed in 35 (85%) patients. The rate of remission for the initial surgery was 85.4% using the standard criteria and 68.3% using strict criteria. Three patients underwent early repeat surgery for the persistent disease as the day 3 cortisol was high (306-555 nmol/L). Once the outcome of this surgery was also included, the overall rate of remission was 90.2% (37/41). None of the patients had meningitis, cerebrospinal fluid leakage, visual deterioration, or vascular injury. Permanent and transient diabetes insipidus (DI) occurred in 9.75% and 26.8% following the first ETSS, respectively. We also noted a single case of CD recurrence in 9 months during the total follow-up period of 84 months. Conclusion: ETSS has satisfactory rates of remission for the primary treatment of CD, with rates being higher for microadenomas. A long follow-up period is needed to assess the rates of recurrence. Patients must be counseled regarding the risk of postop DI, whether transient or permanent, as a possible complication.
Characteristics of a cytotoxic human lymphocyte-dependent antibody.

J. Wunderlich,E. Rosenberg,J. Connolly,J. Parks

DOI: https://doi.org/10.1093/JNCI/54.3.537

1975-03-01

Journal of the National Cancer Institute

Abstract:Lymphocyte-dependent antobody (LDA) from the blood of a patient with choriocarcinoma was characterized in an allogeneic in vitro system. The antibody reacted with specific traget cells, including cells from the patient's husband. Antibody-coated traget cells were damaged by normal lymphocytes from man and other species. Neither cytotoxic, complement-dependent antibody nor sensitized cytotoxic lymphocytes were found in the patient. LDA activity was associated with IgG gamma-globulin by G-200 Sephadex filtration, electrophoretic mobility, and reactivity with anti-IgG, but there was no activity associated with IgM immunoglobulin. Sera from 14 of 16 normal donors lacked detectable LDA activity, and only low levels were found in sera from the other two donors.
Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature

Steven B Carr,Bette K Kleinschmidt-DeMasters,Janice M Kerr,Katja Kiseljak-Vassiliades,Margaret E Wierman,Kevin O Lillehei

DOI: https://doi.org/10.3171/2017.5.JNS162901

2018-11-01

Abstract:OBJECTIVEThe authors report their single-institution experience with the pathological findings, rates of remission, and complications in patients with presumed Cushing's disease (CD) who underwent a two-thirds pituitary gland resection when no adenoma was identified at the time of transsphenoidal surgery (TSS). The authors also review the literature on patients with CD, negative surgical exploration, and histological findings.METHODSThis study is a retrospective analysis of cases found in neurosurgery and pathology department databases between 1989 and 2011. In all cases, patients had been operated on by the same neurosurgeon (K.O.L.). Twenty-two (13.6%) of 161 patients who underwent TSS for CD had no adenoma identified intraoperatively after systematic exploration of the entire gland; these patients all underwent a two-thirds pituitary gland resection. A chart review was performed to assess treatment data points as well as clinical and biochemical remission status.RESULTSOf the 22 patients who underwent two-thirds gland resection, 6 (27.3%) ultimately had lesions found on final pathology. All 6 patients were found to have a distinct adrenocorticotropic hormone (ACTH) cell adenoma. Sixteen (72.7%) of the patients had no tumor identified, with 3 of these patients suspected of having ACTH cell hyperplasia. The follow-up duration for the entire group was between 14 and 315 months (mean 98.9 months, median 77 months). Remission rates were 100% (6/6 patients) for the ACTH cell adenoma group and 75% (12/16) for the group without adenoma. Overall, 18 (81.8%) of the 22 patients had no evidence of hypercortisolism at last follow-up, and 4 patients (18%) had persistent hypercortisolism, defined as a postoperative cortisol level > 5 μg/dl. Of these 4 patients, 1 was suspected of harboring a cavernous sinus adenoma, 2 were found to have lung tumors secreting ACTH, and 1 remained with an undiagnosed etiology. Rates of postoperative complications were low.CONCLUSIONSThe diagnosis and treatment of CD can be challenging for neurosurgeons, endocrinologists, and pathologists alike. Failure to find a discrete adenoma at the time of surgery occurs in at least 10%-15% of cases, even in experienced centers. The current literature provides little guidance regarding rational intraoperative approaches in such cases. The authors' experience with 161 patients with CD, when no intraoperative tumor was localized, demonstrates the utility of a two-thirds pituitary gland resection with a novel and effective surgical strategy, as suggested by a high initial remission rate and a low operative morbidity.
Reversibility of impaired brain structures after transsphenoidal surgery in Cushing’s disease: a longitudinal study based on an artificial intelligence–assisted tool

Bo Hou,Lu Gao,Lin Shi,Yishan Luo,Xiaopeng Guo,Geoffrey S Young,Lei Qin,Huijuan Zhu,Lin Lu,Zihao Wang,Ming Feng,Xinjie Bao,Renzhi Wang,Bing Xing,Feng Feng,Geoffrey S. Young

DOI: https://doi.org/10.3171/2019.10.jns191400

IF: 5.408

2021-02-01

Journal of Neurosurgery

Abstract:OBJECTIVE Cushing’s disease (CD) involves brain impairments caused by excessive cortisol. Whether these impairments are reversible in remitted CD after surgery has long been controversial due to a lack of high-quality longitudinal studies. In this study the authors aimed to assess the reversibility of whole-brain changes in remitted CD after transsphenoidal surgery (TSS), and its correlations with clinical and hormonal parameters, in the largest longitudinal study cohort to date for CD patient brain analysis. METHODS Fifty patients with pathologically diagnosed CD and 36 matched healthy controls (HCs) were enrolled in a tertiary comprehensive hospital and national pituitary disease registry center in China. 3-T MRI studies were analyzed using an artificial intelligence–assisted web-based autosegmentation tool to quantify 3D brain volumes. Clinical parameters as well as levels of serum cortisol, adrenocorticotrophic hormone (ACTH), and 24-hour urinary free cortisol were collected for the correlation analysis. All CD patients underwent TSS and 46 patients achieved remission. All clinical, hormonal, and MRI parameters were reevaluated at the 3-month follow-up after surgery. RESULTS Widespread brain volume loss was observed in active CD patients compared with HCs, including total gray matter (p = 0.003, with false discovery rate [FDR] correction) and the frontal, parietal, occipital, and temporal lobes; insula; cingulate lobe; and enlargement of lateral and third ventricles (p < 0.05, corrected with FDR). All affected brain regions improved significantly after TSS (p 0.05, corrected with FDR). ACTH and serum cortisol changes were negatively correlated with brain volume changes during recovery (p < 0.05). CONCLUSIONS This study demonstrates the rapid reversal of total gray matter loss in remitted CD. The combination of full recovery areas and partial recovery areas after TSS is consistent with the incomplete recovery of memory and cognitive function observed in CD patients in clinical practice. Correlation analyses suggest that ACTH and serum cortisol levels are reliable serum biomarkers of brain recovery for clinical use after surgery.

surgery,clinical neurology
Surgical Outcomes and Multidisciplinary Management Strategy of Cushing's Disease: a Single-Center Experience in China.

Keyi Zhang,Ming Shen,Nidan Qiao,Zhengyuan Chen,Wenqiang He,Zengyi Ma,Xuefei Shou,Shiqi Li,Yao Zhao,Li Pan,Dan Liu,Min He,Zhaoyun Zhang,Yiming Li,Zhenwei Yao,Hongying Ye,Yongfei Wang

DOI: https://doi.org/10.3171/2020.3.focus2067

2020-01-01

Neurosurgical FOCUS

Abstract:OBJECTIVE:The primary aim of this study was to investigate the value of multidisciplinary team (MDT) management in treating patients with Cushing's disease (CD). The secondary aim was to assess the concordance of bilateral inferior petrosal sinus sampling (BIPSS) lateralization with intraoperative observations.METHODS:The authors recruited 124 consecutive patients (128 procedures) who had undergone endoscopic endonasal resection of adrenocorticotropic hormone-secreting pituitary adenomas from May 2014 to April 2018 and assessed their clinical characteristics, surgical outcomes, and adjuvant therapies. The criteria for surgical remission were normalized serum and urinary cortisol levels, which could be suppressed by a low-dose dexamethasone suppression test at 3-months' follow-up without adjuvant treatment.RESULTS:The remission rates of the 113 patients with long-term follow-up (20.3 ± 12.2 months) were 83.2% after surgery alone and 91.2% after adjuvant therapy. The surgical remission rates of macroadenomas, MRI-visible microadenomas, and MRI-negative tumors were 66.7% (12/18), 89.3% (67/75), and 75% (15/20), respectively (p = 0.039). The surgical remission rates had a trend of improvement during the study period (87.5% in 2017-2018 vs 76.5% in 2014, p = 0.517). Multivariate regression analysis showed that a history of previous pituitary surgery (OR 0.300, 95% CI 0.100-0.903; p = 0.032) and MRI-visible microadenoma (OR 3.048, 95% CI 1.030-9.019; p = 0.044) were independent factors influencing surgical remission. The recurrence rate was 3.2% after a mean of 18 months after surgery. The remission rate of postoperative MDT management in patients with persistent disease was higher than non-MDT management (66.7% vs 0%, p = 0.033). In cases with preoperative BIPSS lateralization, 84.6% (44/52) were concordant with intraoperative findings.CONCLUSIONS:MRI-visible microadenoma and primary surgery were independent predictors of surgical remission in CD. The MDT management strategy helps to achieve a better overall outcome. BIPSS may help to lateralize the tumor in MRI-negative/equivocal microadenomas.
Autoimmune Disorders Associated With Surgical Remission of Cushing’s Disease

Dennis Delasi Nyanyo,Masaaki Mikamoto,Francesca Galbiati,Ilan Remba-Shapiro,Kevin Bode,Sara Schoenfeld,Pamela S Jones,Brooke Swearingen,Lisa B Nachtigall,Pamela S. Jones,Lisa B. Nachtigall

DOI: https://doi.org/10.7326/m23-2024

IF: 39.2

2024-02-20

Annals of Internal Medicine

Abstract:BACKGROUND: Glucocorticoids suppress inflammation. Autoimmune disease may occur after remission of Cushing's disease (CD). However, the development of autoimmune disease in this context is not well described.OBJECTIVE: To determine 1) the incidence of autoimmune disease in patients with CD after surgical remission compared with patients with nonfunctioning pituitary adenomas (NFPAs) and 2) the clinical presentation of and risk factors for development of autoimmune disease in CD after remission.DESIGN: Retrospective matched cohort analysis.SETTING: Academic medical center/pituitary center.PATIENTS: Patients with CD with surgical remission and surgically treated NFPA.MEASUREMENTS: Cumulative incidence of new-onset autoimmune disease at 3 years after surgery. Assessment for hypercortisolemia included late-night salivary cortisol levels, 24-hour urine free cortisol (UFC) ratio (UFC value divided by the upper limit of the normal range for the assay), and dexamethasone suppression tests.RESULTS: Cumulative incidence of new-onset autoimmune disease at 3 years after surgery was higher in patients with CD (10.4% [95% CI, 5.7% to 15.1%]) than in those with NFPAs (1.6% [CI, 0% to 4.6%]) (hazard ratio, 7.80 [CI, 2.88 to 21.10]). Patients with CD showed higher prevalence of postoperative adrenal insufficiency (93.8% vs. 16.5%) and lower postoperative nadir serum cortisol levels (63.8 vs. 282.3 nmol/L) than patients with NFPAs. Compared with patients with CD without autoimmune disease, those who developed autoimmune disease had a lower preoperative 24-hour UFC ratio (2.7 vs. 6.3) and a higher prevalence of family history of autoimmune disease (41.2% vs. 20.9%).LIMITATION: The small sample of patients with autoimmune disease limited identification of independent risk factors.CONCLUSION: Patients achieving surgical remission of CD have higher incidence of autoimmune disease than age- and sex-matched patients with NFPAs. Family history of autoimmune disease is a potential risk factor. Adrenal insufficiency may be a trigger.PRIMARY FUNDING SOURCE: Recordati Rare Diseases Inc.

medicine, general & internal

Nutritional outcomes following small bowel transplantation - The first year post-operative nutritional nadir.

Predictors of Durable Remission After Successful Surgery for Cushing Disease: Results From the Multicenter RAPID Registry

Prospective Evaluation of Transsphenoidal Pituitary Surgery in Patients with Cushing's Disease: Delayed Remission and the Role of Postsurgical Cortisol as a Predictive Factor

Bilateral inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome with unknown origin

Clinico-radiological parameters, biochemical and molecular alterations predicting remission and recurrence after surgical treatment of corticotroph adenomas – Cushing's disease

Predicting postoperative hypocortisolism in patients with non-aldosterone-producing adrenocortical adenoma: a retrospective single-centre study

ODP639 The Occurrence and Predictors of Postoperative Adrenal Insufficiency for Patients With Subclinical Cushing's Syndrome

Study of correlative mitigating factors after the surgery for Cushing's disease

1233 A Benchmark for Early Biochemical Success and Long-term Remission After Resection of Corticotroph Adenomas in Cushing Disease

The Diagnosis and Surgical Treatment of Pituitary ACTH- secreting Cushing’s Adenoma

Clinical significance of immediate urine cytology after transurethral resection of bladder tumor in patients with non‐muscle invasive bladder cancer

Surgical Results and Predictors of Initial and Delayed Remission for Growth Hormone-Secreting Pituitary Adenomas Using the 2010 Consensus Criteria in 162 Patients from a Single Center

Preoperative Prognostic Nomogram for Prophylactic Steroid Treatment of Patients with Subclinical Cushing’s Syndrome

Machine learning in predicting early remission in patients after surgical treatment of acromegaly: a multicenter study

A predicted model for postoperative seizure outcomes after the surgical resection of supratentorial cavernous malformations.

Retrospective analysis of the outcomes of endoscopic transsphenoidal surgery for Cushing's disease

Characteristics of a cytotoxic human lymphocyte-dependent antibody.

Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature

Reversibility of impaired brain structures after transsphenoidal surgery in Cushing’s disease: a longitudinal study based on an artificial intelligence–assisted tool

Surgical Outcomes and Multidisciplinary Management Strategy of Cushing's Disease: a Single-Center Experience in China.

Autoimmune Disorders Associated With Surgical Remission of Cushing’s Disease